about
Comparison of indoor contact time data in Zambia and Western Cape, South Africa suggests targeting of interventions to reduce Mycobacterium tuberculosis transmission should be informed by local data.Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts and impact on tuberculosis diagnosis.Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia.The sensitivity and specificity of using a computer aided diagnosis program for automatically scoring chest X-rays of presumptive TB patients compared with Xpert MTB/RIF in Lusaka Zambia.Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained SettingsThe association of hyperglycaemia with prevalent tuberculosis: a population-based cross-sectional study.Age- and Sex-Specific Social Contact Patterns and Incidence of Mycobacterium tuberculosis Infection.Isoniazid to prevent first and recurrent episodes of TB.Prevalence of tuberculosis, HIV and respiratory symptoms in two Zambian communities: implications for tuberculosis control in the era of HIVDiabetes mellitus in Zambia and the Western Cape province of South Africa: Prevalence, risk factors, diagnosis and management.Sensitivity, specificity, and reproducibility of the Capilia TB-Neo assayEffect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial.The Second Zambian National Tuberculosis Drug Resistance survey - a comparison of conventional and molecular methods.Evaluation of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis infections in Zambia and South Africa.Correction: Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings.Point-of-Care Urine Ethyl Glucuronide Testing to Detect Alcohol Use Among HIV-Hepatitis B Virus Coinfected Adults in Zambia.Phase 2b Controlled Trial of M72/AS01 Vaccine to Prevent TuberculosisIntegrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study120. A Randomized Double-blind Trial Assessing the Efficacy of M72/AS01E Vaccine Against Pulmonary Tuberculosis Disease in Adults With Latent Mycobacterium tuberculosis Infection
P50
Q31043943-84545A55-BF40-4EA4-8616-D6B6C3741F89Q33595614-38437F02-E403-44A4-A85B-94A6C6BBF634Q34369989-1D02363B-7BBC-4479-9617-D805257B51E1Q35140397-E9E16D3E-1E48-4AF2-85EA-37446A1E9E95Q35647887-C60FB11B-BBD1-4643-9266-6BD475A54C51Q36213598-96B40725-5B21-4384-AD0F-5FD9730B9E33Q36446258-D4D7C237-1006-4D56-8B4B-11E795845E72Q36447646-08B52A3F-9D29-4261-BFC6-24A5694B8A9EQ37186681-8B4CB9B5-F445-4172-961F-600738B3B7FDQ37196869-C2CEACA3-6E59-462A-AA01-44EFB6C61E91Q37336281-9FC014FC-70AB-48F3-912A-311BAD3C8ACBQ38885348-18C68128-074F-4363-9F2C-EA621DB2F696Q39120260-4C4D87E8-2F2A-4840-900A-AD2F7B24C9E2Q41868119-0C6A93AE-ABE2-4D51-B883-251B62D61D61Q42761797-F59F375F-CFBF-4E24-8269-04C996D00565Q47553396-2CB3A396-A6E2-4742-B392-4B77B20F1BDCQ57069957-AC8E8BC3-BCC6-4FA7-9EBD-891474996F17Q58112932-818B1EFD-B3C2-4798-9070-224D44D7DE04Q59328469-3350A54E-118E-4B51-8593-E7748A98FF55
P50
name
Monde Muyoyeta
@en
Monde Muyoyeta
@nl
type
label
Monde Muyoyeta
@en
Monde Muyoyeta
@nl
prefLabel
Monde Muyoyeta
@en
Monde Muyoyeta
@nl